{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T23:25:44Z","timestamp":1743895544041},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T00:00:00Z","timestamp":1383523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Astellas Pharma Inc. (Tokyo, Japan)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neuropharm.2013.10.030","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T08:17:08Z","timestamp":1383725828000},"page":"10-16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy"],"prefix":"10.1016","volume":"79","author":[{"given":"Nobuhito","family":"Murai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Hamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuya","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.10.030_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/phrs.2000.0794","article-title":"Effects of basic fibroblast growth factor on central nervous system functions","volume":"43","author":"Abe","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0074-7742(02)50079-9","article-title":"Electrophysiologic measures of diabetic neuropathy: mechanism and meaning","volume":"50","author":"Arezzo","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600 mg\/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib5","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/diabetes.53.7.1824","article-title":"Direct insulin signaling of neurons reverses diabetic neuropathy","volume":"53","author":"Brussee","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/mol.109.063081","article-title":"Long-term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms","volume":"77","author":"Calabrese","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(96)03201-0","article-title":"Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine","volume":"68","author":"Calcutt","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138945008783431727","article-title":"Growth factors as therapeutics for diabetic neuropathy","volume":"9","author":"Calcutt","year":"2008","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1113\/expphysiol.1989.sp003362","article-title":"The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats","volume":"74","author":"Cameron","year":"1989","journal-title":"Q.\u00a0J. Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2004.06.026","article-title":"High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury","volume":"497","author":"Colpaert","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3959(93)90059-X","article-title":"Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain","volume":"53","author":"Courteix","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3959(94)90218-6","article-title":"Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics","volume":"57","author":"Courteix","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/00001756-200209160-00016","article-title":"Preferential expression of IGF-1 in small DRG neurons and down-regulation following injury","volume":"13","author":"Craner","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.26.5.466","article-title":"Pain in peripheral neuropathy related to rate and kind of fiber degeneration","volume":"26","author":"Dyck","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","article-title":"Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat","volume":"80","author":"Field","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1015410023132","article-title":"Basic fibroblast growth factor promotes extension of regenerating axons of peripheral nerve: in\u00a0vivo experiments using a Schwann cell basal lamina tube model","volume":"26","author":"Fujimoto","year":"1997","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s004290100205","article-title":"The role of basic fibroblast growth factor in peripheral nerve regeneration","volume":"204","author":"Grothe","year":"2001","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib19","first-page":"76","article-title":"The change of insulin-like growth factor-1 in diabetic patients with neuropathy","volume":"112","author":"Guo","year":"1999","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0889-8529(05)70327-3","article-title":"Diabetes and the nervous system","volume":"25","author":"Harati","year":"1996","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0028-3908(93)90117-L","article-title":"Effects of indeloxazine on hippocampal CA1 pyramidal cell damage following transient cerebral ischemia in the gerbil","volume":"32","author":"Kano","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib22","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/dmrr.359","article-title":"Neuropathic pain and diabetes","volume":"19","author":"Kapur","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-8993(00)02953-X","article-title":"Distinct signaling pathways involved in multiple effects of basic fibroblast growth factor on cultured rat hippocampal neurons","volume":"885","author":"Katsuki","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3959(00)00233-5","article-title":"Analgesic profile of the nicotinic acetylcholine receptor agonist, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain","volume":"86","author":"Kesingland","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0306-4522(02)00372-X","article-title":"Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats","volume":"114","author":"Khan","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1440-1681.2004.03950.x","article-title":"Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy","volume":"31","author":"Kiguchi","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0028-3908(03)00268-5","article-title":"Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats","volume":"45","author":"Koch","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib28","first-page":"193","article-title":"Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain","volume":"47","author":"Kuhad","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1085-9489.2004.09105.x","article-title":"The role of growth factors in diabetic peripheral neuropathy","volume":"9","author":"Leinninger","year":"2004","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1464-5491.1995.tb02086.x","article-title":"Insulin-like growth factor-1 and IGF-1 receptors in diabetic patients with neuropathy","volume":"12","author":"Migdalis","year":"1995","journal-title":"Diabet. Med."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1476-5381.2011.01334.x","article-title":"A\u00a0spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy","volume":"163","author":"Mixcoatl-Zecuatl","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib32","first-page":"2369","article-title":"Effects of indeloxazine hydrochloride (YM-08054) on rat local cerebral glucose utilization in experimentally hypoxic model rats","volume":"8","author":"Miyaoka","year":"1988","journal-title":"Progr. Med."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib33","first-page":"1523","article-title":"Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine","volume":"34","author":"Molteni","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nbd.2011.04.001","article-title":"Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1","volume":"43","author":"Morgado","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib35","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db05-1160","article-title":"Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats","volume":"55","author":"Nakae","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib36","first-page":"91","article-title":"Studies on the diabetogenic action of streptozotocin (NSC-37917)","volume":"29","author":"Rakieten","year":"1963","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.pain.2011.02.024","article-title":"Hypoxia-induced sensitization of transient receptor potential vanilloid 1 involves activation of hypoxia-inducible factor-1 alpha and PKC","volume":"152","author":"Ristoiu","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(74)90136-1","article-title":"Peripheral nerve structure and function in experimental diabetes","volume":"23","author":"Sharma","year":"1974","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0091-3057(93)90248-R","article-title":"Central activating properties of indeloxazine HCl and its optical isomers","volume":"45","author":"Shimizu-sasamata","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00125-006-0169-8","article-title":"Remote neurotrophic support of epidermal nerve fibres in experimental diabetes","volume":"49","author":"Toth","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(02)00491-3","article-title":"Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats","volume":"328","author":"Ulugol","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/PL00005110","article-title":"Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin and 5-HT4 receptors","volume":"356","author":"Yamaguchi","year":"1997","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2009.06.037","article-title":"Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats","volume":"57","author":"Yamamoto","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib44","first-page":"130","article-title":"Pharmacological and biochemical properties of indeloxazine hydrochloride, a new cerebral activator","volume":"3","author":"Yamamoto","year":"1990","journal-title":"Brain Dysfunct."},{"key":"10.1016\/j.neuropharm.2013.10.030_bib45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0028-3908(93)90083-F","article-title":"Effects of indeloxazine hydrochloride, a cerebral activator, on passive avoidance learning impaired by disruption of cholinergic transmission in rats","volume":"32","author":"Yamamoto","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.10.030_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/exnr.1996.0129","article-title":"Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats","volume":"140","author":"Zhuang","year":"1996","journal-title":"Exp. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:24:23Z","timestamp":1539221063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813005066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":46,"alternative-id":["S0028390813005066"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.030","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}